EC Pharmacies's net debt stood at EUR -0.477 mil and accounted for -12.3% of equity at the end of 2024. The ratio is up 14.1 pp compared to the previous year.
Historically, the firm’s net debt to equity reached a high of -12.3% in 2024 and a low of -26.3% in 2023 between 2023 and 2024. The average for the last five years was -19.3%.
Net debt to EBITDA was calculated at 0.632x at the end of the year. ERROR: A non-numeric value encountered That is up from x seen in 2019. The ratio reached a high of 0.632x in 2024 and a low of 0.632x in 2024.
The company’s cost of funding amounted to in 2024, up which is above the 5-year of %. Funding costs have “eaten” some 0% of the operating profit generated in 2019.
You can see all the company’s data at EC Pharmacies profile, or you can download a report on the company in the report section.
Helgi Library 
